Dysregulation of PDE4 activity has been linked to neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD), primarily through the disruption of cAMP/PKA/CREB signaling [23]. This evidence concerns the gene CREB1 and Parkinson disease.